SAN DIEGO, March 24 /PRNewswire/ -- At an investor conference held today, following the market close, Aethlon Medical (OTC Bulletin Board:AEMD.ob - News), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed the following:
